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Background
The number of involuntary admissions in the Netherlands
increased from 40 per 100,000 citizens in 1997 to 48 in
2005. During this period the mental health law did not
change. In the Netherlands patients can be involuntarily
admitted if they have a mental disorder causing danger-
ous behavior. One of the reasons for the increase in com-
mitments may be that there is a shift in dangerousness
criteria medical doctors apply when ordering an emer-
gency involuntary admission.
Method
We used a national database on all emergency involuntary
admission in the Netherlands in the period 1997 – 2005,
containing information about demographics, diagnoses
and dangerousness criteria.
Results
During the period 1997 – 2005 the percentage of patients
having a psychotic disorder was approximately 53%. Dur-
ing this period, the frequency of using 'hard' criteria
including 'suicide risk' and 'violence to others' did not
change, whereas the use of other, 'soft' criteria including
'arousing aggression', 'severe self neglect' and 'severe
social breakdown' as reasons for commitment increased
significantly, from 41% to 54%, 36% to 45%, and 27% to
42%, respectively.
Conclusion
There has been a shift in dangerousness criteria from
'hard' to 'soft', applied to psychotic patients as reasons for
emergency involuntary admissions in the Netherlands,
possibly leading to more commitments.
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